These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 33050329)

  • 1. Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors.
    Sostoa J; Dutoit V; Migliorini D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.
    Zeng J; Li X; Sander M; Zhang H; Yan G; Lin Y
    Front Immunol; 2021; 12():721830. PubMed ID: 34675919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates to the antitumor mechanism of oncolytic virus.
    Bai Y; Hui P; Du X; Su X
    Thorac Cancer; 2019 May; 10(5):1031-1035. PubMed ID: 30900824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.
    Stergiopoulos GM; Concilio SC; Galanis E
    Curr Treat Options Oncol; 2024 Jul; 25(7):952-991. PubMed ID: 38896326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses-immunotherapeutics on the rise.
    Keller BA; Bell JC
    J Mol Med (Berl); 2016 Sep; 94(9):979-91. PubMed ID: 27492706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virotherapy Research in Germany: From Engineering to Translation.
    Ungerechts G; Engeland CE; Buchholz CJ; Eberle J; Fechner H; Geletneky K; Holm PS; Kreppel F; Kühnel F; Lang KS; Leber MF; Marchini A; Moehler M; Mühlebach MD; Rommelaere J; Springfeld C; Lauer UM; Nettelbeck DM
    Hum Gene Ther; 2017 Oct; 28(10):800-819. PubMed ID: 28870120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.
    Watanabe N; McKenna MK; Rosewell Shaw A; Suzuki M
    Mol Ther; 2021 Feb; 29(2):505-520. PubMed ID: 33130314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A viral attack on brain tumors: the potential of oncolytic virus therapy.
    Mokhtarpour K; Akbarzadehmoallemkolaei M; Rezaei N
    J Neurovirol; 2024 Jun; 30(3):229-250. PubMed ID: 38806994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses.
    Thoidingjam S; Bhatnagar AR; Sriramulu S; Siddiqui F; Nyati S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virus therapy: A new era of cancer treatment at dawn.
    Fukuhara H; Ino Y; Todo T
    Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Viruses: Therapeutics With an Identity Crisis.
    Breitbach CJ; Lichty BD; Bell JC
    EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to Oncolytic Virotherapy.
    Engeland CE; Bell JC
    Methods Mol Biol; 2020; 2058():1-6. PubMed ID: 31486028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of oncolytic virotherapy: from genetic modification to combination therapy.
    Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
    Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances.
    Kwan A; Winder N; Muthana M
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
    Russell L; Peng KW; Russell SJ; Diaz RM
    BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.
    Liu H; Luo H
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
    Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
    Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
    Suryawanshi YR; Schulze AJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.